基于凝血功能、血小板水平评估低分子肝素对复发性流产易栓症的治疗效果

doi:10.3969/j.issn.1001-8131.2025.01.002

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (559 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To judge the curative properties of low-molecule heparin（LMWH）on recurring abortion hemorrhage via seeking clot activity and the platelet count. Methods A aggregate of 116 recipients of frequent abortion embolism came to our unit were utilized and isolated under two sections：regulate（58 instances）and seeing（58 examples）,utilising a blind selected separating tool.The placebo group began routine infant care rehabilitation,versus the observers underwent both therapies with low-MW heparin on an identical principles as the unaffected team,and proceeded being given chemotherapy for 4 weeks.The hemoglobin search,blood count,poor delivery results,and hazardous drug reply occurred in the two pairs. Results The initial result verified the same trend（P>0.05）.Upon care,APTT,PT,and TT bumped although FIB sank.APTT（33.62±3.97）s,PT（13.37±0.75）s,and TT（15.49±0.78）were far more in the trial unit instead of the blank lab,whilst FIB（2.71±0.24）g/L was below.P<0.05.During remedy,all customers platelet activity slipped.The clinical arm had a far lower platelet numbers（231.58±18.06）×10⁹/L versus the placebo cohort（P<0.05）.The participant team had a notably lower risk for unfavorable birth（10.34%）relative to the placebo unit（25.86%,P<0.05）.The trial sample had cheaper contrary drug reactions juxtaposed to the placebo cohort. Conclusion Low moles of histamine has an uplifting impact in the care of ongoing abortion bleeding folks,honing bleeding development,cutting platelet counts in the tissues and minimizing the chance of poor pregnancies,and putting minimal hurt drug action,proving it suitable of growth and consumption in hospitals.

Key words： Coagulation function Platelet level Low molecular weight heparin Recurrent abortion thrombophilia

Received: 10 February 2025

PACS:

R714.21

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Zhang Haitao
	Zhang Qihang
	Lu Linjun

Cite this article:

Zhang Haitao,Zhang Qihang,Lu Linjun. To Evaluate the Therapeutic Effect of Low Molecular Weight Heparin on Recurrent Abortion Susceptibility Based on Coagulation Function and Platelet Level[J]. journal1, 2025, 45(1): 4-4.

URL:

http://www.hrbyybjb.org.cn/EN/10.3969/j.issn.1001-8131.2025.01.002 OR http://www.hrbyybjb.org.cn/EN/Y2025/V45/I1/4

[1] 丁仲军,毛宝宏,倪亚莉,等.NOS3,IL-1β基因多态性与不明原因复发性流产相关性的研究进展[J].中国性科学,2024,33(4):66-70.
[2] 胡桂英,陈文芬,邱少红.阿司匹林联合参归养血片孕前干预对ACA阳性复发性流产患者易栓症及再次妊娠效果[J].中国计划生育学杂志,2022,30(2):301-305,310.
[3] Bistervels IM,Buchmüller A,Wiegers HMG,et al.Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism(Highlow study):an open-label,multicentre,randomised,controlled trial[J].Lancet,2022,400(10365):1777-1787.
[4] Tian Y,Fu Z,Lan H,et al.Chinese traditional herbs enhanced the clinical efficacy of low-molecular-weight heparin in the treatment of recurrent spontaneous abortion complicated with thrombophilia[J].Heliyon,2023,9(2):e13120.
[5] 孙凌,许丽梅,张学武,等.多普勒超声子宫动脉血流参数联合凝血相关指标对易栓症所致复发性流产妊娠结局的预测价值[J].中国医学装备,2024,21(3):73-77.
[6] 张赛男,李俊峰,白爱红,等.低分子肝素治疗复发性流产的临床疗效及安全性[J].中国药物与临床,2024,24(6):400-403.
[7] 李洁. 2016年中国“复发性流产诊治的专家共识”与2017年欧洲“复发性流产诊治指南”的解读[J].实用妇产科杂志,2018,34(11):822-825.
[8] 张译爻,王玉贤,崔向荣.复发性流产与遗传性易栓症的研究进展[J].中国临床研究,2022,35(10):1449-1453.
[9] 刘世茸,李楠,狄静,等.从络脉瘀阻探讨反复自然流产易栓症的病机及治疗思路[J].吉林中医药,2022,42(7):758-761.
[10] 杨琳,左文婷.益肾安胎化瘀方对肾虚血瘀型早期先兆流产合并绒毛膜下血肿患者凝血指标及妊娠结局的影响[J].中国中西医结合杂志,2024,44(1):31-36.
[11] 徐莉,孙萍.补中益气汤联合地屈孕酮片治疗早期先兆流产的疗效观察[J].中国处方药,2023,21(4):112-115.
[12] 王振兴,毛永辉,王源,等.抗Ⅹa因子活性评估血液透析低分子肝素抗凝的效果[J].中华预防医学杂志,2024,58(02):254-260.
[13] 李燕燕,李雄英.低分子肝素对复发性流产患者凝血功能、血栓弹力图的影响[J].中国性科学,2023,32(1):52-55.
[14] 温凤云,宋秀云,邓翠艳,等.阿司匹林联合低分子肝素钠治疗复发性流产血栓前状态疗效及对凝血功能,激素水平及子宫血流动力学的影响[J].中国妇产科临床杂志,2024,25(3):259-261.
[15] 王振兴,徐冷楠,付沛颉,等.抗Xa因子活性检测在血液透析患者低分子肝素抗凝中的应用进展[J].中国血液净化,2022,21(5):365-368.
[16] 邱春萍,曹爱娥,钟威达,等.低分子肝素钠联合保胎灵在复发性流产患者中的应用价值及对CRP与HO-1的影响[J].标记免疫分析与临床,2024,31(2):259-263.
[17] Cools F,Virdone S,Sawhney J,et al.Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated,at-risk outpatients with COVID-19(ETHIC):an open-label,multicentre,randomised,con-trolled,phase 3b trial[J].Lancet Haematol,2022,9(8):e594-e604.
[18] 徐畅,王秋实.低分子量肝素对子痫前期产妇产后凝血指标的影响[J].临床输血与检验,2022,24(1):28-32.
[19] Bistervels IM,Wiegers HMG,Ainle FN,et al.Onset of labor and use of analgesia in women using thromboprop-hylaxis with 2 doses of low-molecular-weight heparin:insights from the Highlow study[J].J Thromb Haemost,2023,21(1):57-67.